The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     

The Annals of Pharmacotherapy: Vol. 34, No. 5, pp. 662-665. DOI 10.1345/aph.19259
© 2000 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davydov, L
Right arrow Articles by Botts, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davydov, L
Right arrow Articles by Botts, S.

Research Articles

Clozapine-induced hypersalivation

L Davydov and SR Botts

OBJECTIVE: To review underlying pathophysiology and possible treatments for clozapine-induced hypersalivation. DATA SOURCES: Primary literature was accessed through MEDLINE (1966-May 1999). Key search terms included clozapine, hypersalivation, sialorrhea, and treatment. DATA SYNTHESIS: Hypersalivation occurs in up to 54% of patients receiving clozapine. An evaluation of studies and case reports focusing on management of clozapine-induced hypersalivation was conducted. CONCLUSIONS: It is unclear whether clozapine increases salivation through its muscarinic M4 receptor activation and/or blockade of alpha2-adrenoceptors, or by causing a distortion in swallowing reflex. Treatment options include chewing gum, reducing the dosage of clozapine, or prescribing pharmacologic agents such as anticholinergics or alpha2-adrenoceptor agonists.


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
A. R Kunwar, E. Doufekias, N. Nihalani, and M. M Iqbal
Ipratropium bromide for treatment of bethanechol-induced sialorrhea
Ann. Pharmacother., September 1, 2003; 37(9): 1343 - 1343.
[Full Text] [PDF]

Home page
 Journal of the American Dental AssociationHome page
Anticholinergics
J Am Dent Assoc, July 1, 2001; 132(7): 1021 - 1022.
[Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2000 by Harvey Whitney Books Company.